receptor as well as phosphorylation of certain intracellular proteins. The intracellular messenger system that transmits the mitogenic signal from the receptor and to the nucleus is still largely unknown. Recent observations have indicated that the cellular homologue to the oncogene myc might be involved; stimulation of cells with PDGF leads to increased expression of rnyc with a maximum after 2 h (Kelley et al., 1983) . A possible function for the PDGF-receptor-associated kinase may then be to activate proteins which specifically regulate the transcription of myc or of other genes coding for proteins involved in the regulation of mitogenesis.
Factors (Guroff, G., ed.), vol. 1, The insulin receptor-kinase complex: an integrated system for transmembrane hormone signalling The native insulin receptor is a high molecular weight complex and appears to be minimally composed of two M,
Abbreviations used : EGF, epidermal growth factor; PDGF, plateletderived growth factor; SDS, sodium dodecyl sulphate; TGF, tumour growth factor. 130000 (u-subunit) and two M, 95000 (p-subunit) glycoprotein subunits linked together by disulphide bonds. Binding of insulin to its cell-surface receptors on target cells initiates an elaborate programme of biochemical processes eventuating in the final hormonal effects (Kahn et al., 1981; Van Obberghen & Khan, 1981) . The molecular basis of insulin action is poorly comprehended, but recently promising progress has been achieved by the demonstration that the insulin receptor is an insulin-activatable protein kinase (Kasuga et al., 1982a (Kasuga et al., ,b,c, 1983 Van Obberghen & Kowalski, 1982; Van Obberghen et al., 19836; Gazzano et al., 1983; Petruzelli et al., 1982; Avruch et al., 1982; Roth & Cassell, 1983; Shia & Pilch, 1983) . This novel observation is particularly intriguing for our understanding of insulin-regulated processes, since it is now widely accepted that hormone-modulated protein phosphorylation4ephos-phorylation reactions play a crucial role in the regulation of cellular events, including those mediated by insulin. In the present review we will briefly recount our own data on insulin receptor phosphorylation, and discuss its possible role in transmembrane hormone signalling.
Phosphorylation of insulin receptors in intact hepatocytes
To investigate whether insulin receptors can be phosphorylated in intact hepatocytes, isolated rat hepatocytes were first incubated with [32P]orthophosphate and then without or with insulin. After solubilization and partial purification by lectin chromatography insulin receptors were specifically precipitated with antireceptor antibodies and analysed by SDS/polyacrylamide-gel electrophoresis under reducing conditions. When solubilized labelled glycoproteins obtained from cells incubated in absence of insulin were precipitated with antireceptor antibodies a major labelled band was found with Mr 95000 (Van Obberghen & Kowalski, 1982) . We recognize this molecular species as the P-subunit of the insulin receptor for the following reasons. First, non-immune serum did not precipitate a labelled band with a similar electrophoretic mobility. Second, using biosynthetic and affinity labelling methods, we have previously identified the P-subunit of the insulin receptor with identical electrophoretic mobility (Van Obberghen et al., Kasuga et al., 1981a,b; Hedo et al., 1981; Van Obberghen, 1984) . Insulin induced consistently a 30-50% increase in the labelling of its own receptor P-subunit. This effect of insulin is specific, since EGF, which binds to and increases the phosphorylation of its own receptors in these cells, was without effect on insulin receptor phosphorylation. Phosphoamino acid analysis of the insulin receptor P-subunit revealed the presence of phosphothreonine and Labelled receptors were then exposed to antireceptor serum (c-e) or normal serum (a, b). The immune precipitates were analysed by SDS/polyacrylamide-gel electrophoresis under reducing conditions, followed by radioautography .
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VOl. 12 phosphoserine when the cells were labelled in absence of insulin. Further, the stimulatory action of insulin on receptor phosphorylation was accounted for by an increase in phosphoserine (Gazzano et al., 1983).
Phosphorylation of insulin receptors in cell-free systems
To further characterize the molecular basis of insulin receptor phosphorylation we have used a cell-free system. In brief, partially purified insulin receptors were incubated with [y-)*P]ATP in absence or presence of insulin. Thereafter, the insulin receptors were specifically precipitated with antireceptor antibodies. SDS/polyacrylamide-gel electrophoresis analysis of the immune precipitates under reducing conditions revealed that a major band of Mr 95000 was phosphorylated in the basal state (Van Obberghen & Kowalski, 1982) (Fig. 1) . Again, this Mr 95000 phosphoprotein was identified as the P-subunit of the insulin receptor by its specific immunoprecipitation by antireceptor antibodies and by its electrophoretic mobility, which was identical to that found for the receptor P-subunit labelled by various techniques. Similar to its effect in intact cells, insulin increased 24-fold the phosphorylation of its Mr 95000 receptor subunit. Further, the dose-relationship of insulin's effect on phosphorylation of its receptor P-subunit was remarkably similar to that previously described in our laboratory for insulin binding to the high-affinity component in these hepatocytes (Fehlmann et a[., 1981) . This stimulation by insulin is specific, since EGF and glucagon had no effect. The stimulatory action of insulin on its receptor phosphorylation is therefore characterized by the typical affinity and specificity of a receptor-mediated insulin effect.
To address the question of the physical inter-relationship between the insulin receptor and the kinase phosphorylating the receptor, we investigated whether the insulin receptor isolated by specific immunoprecipitation is a substrate for phosphorylation (Van Obberghen et al., 19833). important, insulin increased several-fold the phosphorylation of the immunoprecipitated insulin receptor, indicating that antireceptor antibodies precipitate a functional insulin-stimulatable kinase activity, which is contained in, or closely associated with, the receptor. Insulin's effect on its own receptor phosphorylation appears to be independent of cyclic AMP and calcium. Further, in cell-free systems the insulin receptor is phosphorylated on tyrosine residues, and insulin's stimulatory action on its receptor phosphorylation is largely accounted for by an increase in phosphotyrosine (Gazzano et al., 1983).
Identification of an ATP-binding site on the insulin receptor
To localize more precisely the kinase activity phosphorylating the insulin receptor, we searched for a potential ATPbinding site on the insulin receptor using covalent affinity labelling (Van Obberghen et af., 1983b). When partially purified insulin receptors were first incubated with oxidized [u-~*P]ATP and NaBH,CN, and then subjected to immunoprecipitation, a unique and major labelled polypeptide of Mr 95000 was precipitated with antireceptor antibodies. We recognize this polypeptide as the insulin receptor /?-subunit based on its electrophoretic mobility and the established specificity of the antireceptor antibodies. Further, when immunoprecipitation was preceded by incubation with excess unlabelled insulin, this 32P-labelled polypeptide was no longer precipitated by antireceptor anti bodies.
Insulin receptor dephosphorylation
For the biological relevance of the concept of insulin receptor phosphorylation as a crucial early step in insulin action, the covalent modification of the receptor must be reversible, and regulated by cellular protein phosphatases. Therefore, we have addressed the following questions of (i) the reversibility of insulin receptor phosphorylation, and (ii) the existence of a putative protein phosphatase activity associated with insulin receptors (Van Obberghen et a[., 1983~) .
We first investigated whether partially purified insulin receptors obtained by wheat germ lectin chromatography could be dephosphorylated. To this end partially purified receptors were first incubated with [Y-~~PIATP together with insulin to allow for maximal phosphorylation. When the phosphorylated partially purified insulin receptors were incubated with an excess of unlabelled ATP, a rapid decrease in the labelling of the insulin receptor B-subunit was observed (Fig. 3) . Thus quantitative scanning revealed a loss in 32P from the p-subunit noticeable after 1 min, and a t, of dephosphorylation of approximately 15min. This dephosphorylation was unaltered by insulin. To investigate whether a putative phosphatase activity is found in the insulin receptor itself, we studied dephosphorylation of immunoprecipitated receptors. In brief, partially purified receptors were first specifically precipitated with antireceptor antibodies, and then incubated with [y-32P]ATP. After addition of excess unlabelled ATP to study possible dephosphorylation, the level of phosphorylation of immunoprecipitated insulin receptors remained stable for a period up to a 4h. However, when a cytosol prepared from hepatocytes was added, a virtually total dephosphorylation of the receptor 0-subunit was observed. Further, the action of the cytosolic phosphatases was completely blocked by vanadate (Kowalski et al., 1983) .
In conclusion, a phosphatase activity copurifies with insulin receptors on lectin chromatography, but this enzymic activity is no longer detected in highly purified receptors, indicating that is not an integral constituent of the receptor molecule. However, the highly purified insulin Time at 24°C (min) Fig. 3 . Dephosphorylation of partially purijied insulin receptors Partially purified insulin receptors were first phosphorylated and then incubated with unlabelled ATP to study dephosphorylation. At different time intervals aliquots were taken, the reaction was stopped and insulin receptors were immunoprecipitated with antireceptor antibodies. The immune precipitates were analysed by SDS/polyacrylamide-gel electrophoresis under reducing conditions followed by radioautography.
receptor remains very sensitive to phosphatases present in cytosol derived from hepatocytes.
Insulin receptor kinase activity towards exogenous protein substrates
We first investigated whether partially purified insulin receptors were able to catalyse the phosphorylation of histone and casein. Both protein substrates were found to be phosphorylated by partially purified insulin receptors. More important, insulin enhanced the insulin receptor kinase activity, resulting in a several-fold increase in 32P incorporation into histone and casein. We next examined the insulin receptor kinase activity present in immunoprecipitated receptors towards exogenous protein substrates. Similar to our findings with partially purified insulin receptors, both substrates were phosphorylated by immunoprecipitated receptors, and their phosphorylation was found to be increased several-fold by insulin. Concerning the amino acids phosphorylated in protein substrates, we observed differences depending on the nature of the receptor preparation used as a protein kinase source. Thus when the protein substrates were phosphorylated by partially purified insulin receptors, we found under basal phosphorylation conditions (i.e. absence of insulin), phosphoserine, phosphothreonine and phosphotyrosine. Insulin induced a 3-5-fold increase in 32P-incorporation in phosphotyrosine, and has in addition a smaller, but consistent, stimulating effect on the labelling of phosphoserine. We next identified the amino acids phosphorylated by immunoprecipitated insulin receptors in casein and histone. When these substrates were phosphorylated in absence of insulin, the major labelling occurred on phosphotyrosine ; only minute amounts of phosphoserine and phosphothreonine were found. However, the stimulating action of insulin on 32P incorporation was limited to an increase in phosphotyrosine. The amounts of the other amino acids were not significantly modified.
Summary and conclusion
Hormone-modulated protein phosphorylationdephosphorylation reactions have been known for several years now to play a crucial role in the control of cellular processes (Cohen, 1982 Our own data summarized here allow us to conclude that the insulin receptor is an insulin-activatable protein kinase. We reached this conclusion based on the observation that the receptor /?-subunit isolated by specific immunoprecipitation is a substrate for insulin-stimulated phosphorylation, and that an ATP-binding site on this same receptor subunit has been identified. The insulin receptor is not only a kinase capable of self-phosphorylation, but is also able to catalyse the phosphorylation of exogenous substrates. The nature of the amino acids phosphorylated in the receptor /?-subunit itself, and in protein substrates, deserves special attention. Thus in intact cells the receptor 8-subunit is phosphorylated on serine residues, and insulin's effect is accounted for by an increase in phosphoserine. In contrast, in cell-free systems phosphotyrosine is the only amino acid found in the receptor B-subunit, both in absence or presence of insulin. However, a different pattern is observed with protein substrates. Thus partially purified receptors catalyse the phosphorylation of proteins on both serine and tyrosine, whereas with the receptors purified by immunoprecipitation only tyrosine is found to be phosphorylated.
Taking the data on receptor and substrate phosphorylation together, we have proposed the following model for the insulin receptor and its associated kinase activities. We envisage an insulin receptor-kinase complex with two separate protein kinases, a tyrosine-and a serine-specific kinase. The tyrosine-specific kinase would be a constituent of the insulin receptor, and supported by the existence of an ATP-binding site on the receptor b-subunit, this kinase would be contained in the receptor B-subunit itself. In contrast, the serine-specific kinase would be tightly associated with the insulin receptor in the cell membrane, but would not form an integral part of the receptor. This picture of the insulin receptor-kinase complex explains our data on receptor phosphorylation in intact cells and cell-free systems. Insulin binds to the a-subunit of the insulin receptor, and then, likely through a conformational change, activates both the tyrosine-specific and the serine-specific kinase. In intact cells, only serine residues would be accessible, whereas solubilization would result in a conformational change of the receptor B-subunit concomitantly masking the serine residues and uncovering the tyrosine residues. Concerning the kinase activity of the receptor complex towards exogenous substrates, the nature of amino acids phosphorylated would depend on the tyrosine kinase activity of the receptor 8-subunit, and the presence or absence of the receptor-associated serine kinase activity. Our data also indicate that insulin receptor phosphorylation is endowed with the necessary reversibility requirements for a regulatory event in insulin action. However, the receptor itself does not contain a phosphatase activity and the hormone is without effect on its receptor dephosphorylation.
The biological relevance of insulin receptor phosphorylation is not known. We favour the concept that this insulinregulated covalent receptor modification is an early step in Vol. 12 insulin action, and that the insulin receptor is in fact an integrated system for transmembrane hormone signalling. In accord with this idea the increased kinase activity of the insulin receptor evoked by hormone binding would lead to phosphorylation-dephosphorylation of other cellular proteins, and through the generation of a cascade of reactions this would result in the final effects of insulin. The relationship between the two protein kinase activities associated with the insulin receptor and their roles remains to be established. At least two situations are possible, one in which both kinases serve separate cellular functions, and another one with sequential activation of the kinases. In regards to the first possibility, tyrosine-specific protein kinases have been implicated in cellular responses to growth factors, such as EGF (Ushiro & Cohen, 1980; Cohen er al., 1982) , PDGF (Ek et al., 1982) , TGF (Reynolds er al., 1981) and in cell transformation induced by oncogenic viruses (Hunter & Sefton, 1980; Collett et al., 1980) . It is therefore an appealing idea to conceive that this tyrosine-specific enzyme activity is involved in the generation of signals regulating insulin's mitogenic action. In contrast, the serinespecific protein kinase would play a role in the metabolic processes controlled by insulin. All the known enzymes playing a role in cellular intermediary metabolism and whose activity is modulated by insulin through phosphorylation-dephosphorylation reactions are indeed modified on serine residues. Alternative to this model implying separate functions for the kinases exists the possibility where one kinase activates the other, and this last one accounts for the generation of the cellular responses to insulin. As the tyrosine-specific kinase is likely a constituent of the insulin receptor, in this model with sequential activation of kinases insulin binding to its receptor would lead to activation of the tyrosine-specific kinase, which then induces activation of the receptor-associated serine kinase.
In conclusion, the data available are consistent with the idea that the insulin receptor fulfils the requirements for a system regulating transmembrane hormone signalling. A major advance for the relevance of this contention will be the demonstration that receptor phosphorylation is necessary and sufficient for insulin to act.
One of the central features of insulin's action on the liver is its ability to antagonize the actions of glucagon. Glucagon switches on glycogenolysis and gluconeogenesis in the liver by raising intracellular cyclic AMP concentrations through stimulating the activity of adenylate cyclase. Insulin would appear to achieve its antagonistic effect by causing a decrease in the intracellular concentrations of cyclic AMP.
Although insulin is known to exert actions on target cells which are independent of alterations in intracellular cyclic AMP concentrations, we believe that adenylate cyclase and cyclic AMP phosphodiesterases can be employed as useful probes to identify aspects of insulin's molecular mechanism of action.
Intracellular concentrations of cyclic AMP are determined by the action of adenylate cyclase, a plasmamembrane enzyme, and a family of cyclic AMP phosphodiesterases, which occur as both soluble and particulate forms (see Houslay et af., 1983). If hepatocytes are incubated with insulin then we (Heyworth et al., 19836) have been able to demonstrate that the activity of two distinct cyclic AMP phosphodiesterases is markedly increased. These are a plasma-membrane enzyme and the so-called 'dense-vesicle' enzyme, which is found associated with an intracellular membrane fraction.
The plasma-membrane enzyme has been studied by us (Marchmont & Houslay, 1980a; Marchmont et al., 1981) in some detail. It is a monomeric enzyme which expresses high affinity for cyclic AMP, but not cyclic GMP, yet exhibits kinetics indicative of apparent negative co-operativity. This is believed to be due to it obeying an unusual type of kinetic mechanism (mnemonical), which enhances the degree of activation achieved at physiological substrate concentrations. This enzyme is found loosely associated with the plasma membrane and can be displaced by increasing the ionic strength or the addition of chelating agents such as EGTA/EDTA. It can thus be considered a peripheral membrane protein. Nevertheless, it is found specifically associated with the plasma membrane where it binds to a single species of integral membrane protein (Marchmont &  Houslay, 198 1) . The plasma-membrane phosphodiesterase, is presumably anchored to this location within the cell as it is not found associated with any other membrane fraction (Cercek & Houslay, 1982; Cercek et al., 1983) . From binding studies and from our purification procedures it is possible to estimate that about 26000 copies of this phosphodiesterase are associated with the plasma membrane of each hepatocyte. This is of a similar magnitude to the number of insulin receptors in these cells.
How is the plasma membrane phosphodiesterase activated by insulin? It is possible to achieve activation of this enzyme, by insulin, in a broken membrane fraction (Marchmont & Houslay, 19806) . This, however, involves the incubation of purified plasma membranes with not only insulin but also MgATP and cyclic AMP for about 3-5min at 30°C. After such an incubation the phosphodiesterase is activated almost 2-fold. The process is concentration dependent upon insulin, cyclic AMP and MgATP, with half-maximal effects occurring at 0.1 nM, 1.6pM and 25 p~ respectively. Considering that the intracellular concentrations of cyclic AMP are of this order of magnitude and MgATP concentrations are well in excess of this, then we can expect that physiological concentrations of insulin would trigger the activation of this enzyme in intact hepatocytes. This we have indeed observed (Heyworth et al., 19836) .
The requirement for both MgATP and cyclic AMP to elicit activation of the phosphodiesterase by insulin suggested that a phosphorylation process might be involved. Indeed if activation was performed using [p3*P]-ATP then we were able to purify a phosphorylated form of the enzyme (Marchmont & Houslay, 1981) . It contained approximately 1 mol of alkali-labile phosphate per mol of enzyme. This could be removed by the action of either alkaline phosphatase or the endogenous phosphatase activity of rat liver cytosol. Such treatment caused the activity of the enzyme to resume that exhibited by the native enzyme. Furthermore, if plasma-membrane fractions containing the enzyme were obtained from hepatocytes treated with insulin, then alkaline phosphatase treatment also caused their phosphodiesterase activity to resume that observed in the basal state (Heyworth et al., 19836) . This suggests that both in hepatocytes and in broken plasmamembrane fractions, insulin exerts its stimulatory effect on
